# Spire Healthcare Group PLC (SPI.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Healthcare / Health Care Equipment & Supplies. Price 245p, market value 981 millionp.

## Valuation
- **P/E (trailing): 61.3×** (5-yr avg 5529.3×, 3-yr avg 3737.0×). Spire Healthcare Group PLC trades at 61.3× trailing earnings, well below its own five-year average of 5529.3×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 16.2×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.3×**. Each dollar of revenue is priced at 0.3×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 4.8×**. Enterprise value is 4.8× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 27.5%** (5-yr avg 0.1%). Free cash flow equals 27.5% of the market value, above its five-year average of 0.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 1.6%**. The inverse of the P/E: 1.6% of the price is earned each year.

## Profitability
- **Gross margin: 41.5%**. Spire Healthcare Group PLC keeps 41.5% of revenue after the direct cost of what it sells.
- **Operating margin: 8.5%**. 8.5% of revenue is left after running the business.
- **Net margin: 1.0%**. 1.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 2.2%**. 2.2% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 9.9%**. Return on all capital, debt included, is 9.9%.
- **Return on assets: 1.8%**. Each dollar of assets produces 1.8% of profit.

## Growth
- **Revenue growth (1 yr): 4.5%** (3-yr 9.6%/yr, 5-yr 11.4%/yr). Revenue grew 4.5% over the last year, against 11.4% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -34.4%** (3-yr 24.7%/yr). Earnings per share fell 34.4%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 25.2%/yr**. Free cash flow has compounded at 25.2% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 1.77**. Debt is 1.77 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 2.7×**. It would take 2.7 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 1.3×**. Operating profit covers interest only 1.3×: fragile.
- **Current ratio: 0.63** (quick 0.49). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.60**. A Z-score of 1.60 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.63%** (0p per share, trailing). Spire Healthcare Group PLC yields 0.63%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 56%** (10% of free cash flow). 56% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 3**. 3 straight years of increases.
- **Shareholder yield: 1.9%**. Dividends plus net buybacks return 1.9% of the market value a year.

## Price and momentum
- **Total return (1 yr): 15.8%** (YTD 47.0%, 3-mo 12.9%). The shares are up 15.8% over twelve months including dividends.
- **From 52-week high: -4.5%** (74.0% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 70**. An RSI of 70 is neutral.
- **Beta (1 yr): 0.76** (volatility 66%). Beta of 0.76 against the FTSE All-Share: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SPI.L · Page: https://foliofundamentals.com/stocks/spi.l

Not investment advice.